Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
New pharmacological treatments for improving renal outcomes in diabetes.
Declèves AE, Sharma K
Kumar Sharma on 8/12/2010
Nature reviews. Nephrology
Volume : Pages
6 : 371 - 380
Diabetic nephropathy is the most common and most rapidly growing cause of
end-stage renal failure in developed countries. Diabetic nephropathy results
from complex interactions between genetic, metabolic and hemodynamic factors.
Improvements in our understanding of the pathogenesis of fibrosis associated
with diabetic kidney disease have led to the identification of several novel
targets for the treatment of diabetic nephropathy. Albuminuria is a useful
clinical marker of diabetic nephropathy, as it can be used to predict a decline
in renal function. A reduction in albuminuria might not, however, be reflective
of a protective effect of therapies focused on ameliorating renal fibrosis.
Although new strategies for slowing down the progression of several types of
renal disease have emerged, the challenge of arresting the relentless
progression of diabetic nephropathy remains. In this Review, we discuss novel
pharmacological approaches that aim to improve the renal outcomes of diabetic
nephropathy, including the use of direct renin inhibitors and statins. We also
discuss the promise of using antifibrotic agents to treat diabetic nephropathy.
The need for novel biomarkers of diabetic nephropathy is also highlighted.
Investigators with authorship
University of California San Diego
Neuropathy & Neurocognition
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!